共 154 条
[1]
Cindolo L(2005)Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study Cancer. 104 1362-1371
[2]
Patard JJ(2001)A postoperative prognostic nomogram for renal cell carcinoma J Urol. 166 63-67
[3]
Chiodini P(2003)Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials Cancer. 97 1663-1671
[4]
Kattan MW(2013)Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma–results from a comprehensive multi-centre database (CORONA/SATURN-Project) BJU Int. 112 909-916
[5]
Reuter V(2005)Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma J Clin Oncol. 23 133-141
[6]
Motzer RJ(1998)Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d’Immunotherapie N Engl J Med. 338 1272-1278
[7]
Katz J(2010)Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival J Clin Oncol. 28 2144-2150
[8]
Russo P(2008)Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 J Clin Oncol. 26 5422-5428
[9]
Leibovich BC(1998)Resection of metastatic renal cell carcinoma J Clin Oncol. 16 2261-2266
[10]
Blute ML(1994)Surgeon’s role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review Ann Surg Oncol. 1 345-352